Bacteria-related spontaneous and therapeutic remission of human malignancies

In Vivo

Volumn 16, Issue 6, 2002, Pages 551-556

  Nagorsen, Dirk ^a   Marincola, Francesco M ^a   Kaiser, Hans E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Bacteria; Immunology; Remission; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; CANCER VACCINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

BACTERIAL INFECTION; BACTERIUM EXAMINATION; CANCER; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CANCER RESEARCH; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION ANALYSIS; CPG ISLAND; DISEASE SEVERITY; EXPRESSION VECTOR; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; VACCINATION; ACTIVE IMMUNIZATION; BACTERIUM; IMMUNOLOGY; NEOPLASM; REMISSION; TUMOR REGRESSION;

BACTERIA; BACTERIAL INFECTIONS; HUMANS; IMMUNOTHERAPY, ACTIVE; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASMS; REMISSION INDUCTION;

EID: 0036863134     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Smyth MJ, Godfrey DI and Trapani JA: A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2(4): 293-9, 2001.
2. Rosenberg SA: Progress in human tumour immunology and immunotherapy. Nature 411(6835): 380-4, 2001.
3. Keilholz U, Webber J, Finke JH, Gabrilovich DI, Kast WM, Disis NIL, Kirkwood JM, Scheibenbogen C, Schlom J, Maino VC, Lyerly HK, Lee PP, Storkus W, Marincola F, Worobec A and Atkins MB: Immunologic monitoring of cancer vaccine therapy: Results of a workshop sponsored by the Society for Biological Therapy. J Immunnother 25: 97-138, 2002.
4. Nielsen MB and Marincola FM: Melanoma vaccines: The paradox of T cell activation without clinical response. Cancer Chemother Pharmacol 46 Suppl: S62-6, 2000.
5. Monsurro V, Nagorsen D, Wang E, Provenzano M, Dudley ME, Rosenberg SA and Marincola FM: Functional heterogeneity of vaccine-induced CD8+ T-cells. J Immunol 168(11): 5933-5942, 2002.
6. Fuchs EJ and Matzinger P: Is cancer dangerous to the immune system? Semin Immunol 8(5): 271-80, 1996.
7. Bametson RS and Halliday GM: Regression in skin tumours: A common phenomenon. Australas J Dermatol 38 Suppl 1: S63-5, 1997.
8. Blessing K and McLaren KM: Histological regression in primary cutaneous melanoma: Recognition, prevalence and significance. Histopathology 20(4): 315-22, 1992.
9. Drobyski WR and Qazi R: Spontaneous regression in non-Hodgkin's lymphoma: Clinical and pathogenetic considerations. Am J Hematol 31(2): 138-41, 1989.
10. Homing SJ and Rosenberg SA: The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 311(23): 1471-5, 1984.
11. Bulkley GB, Cohen MH, Banks PM, Char DH and Ketcham AS: Long-term spontaneous regression of malignant melanoma with visceral metastases. Report of a case with immunologic profile. Cancer 36(2): 485-94, 1975.
12. Hurwitz PJ: Spontaneous regression of metastatic melanoma. Ann Plast Surg 26(4): 403-6, 1991.
13. Bottger D, Dowden RV and Kay PP: Complete spontaneous regression of cutaneous primary malignant melanoma. Plast Reconstr Surg 89(3): 548-53, 1992.
14. Avril MF, Charpentier P, Margulis A and Guillaume JC: Regression of primary melanoma with metastases. Cancer 69(6): 1377-81, 1992.
15. Shai A, Avinoach I and Sagi A: Metastatic malignant melanoma with spontaneous and complete regression of the primary lesion. Case report and revieww of the literature. J Dermatol Surg Oncol 20(5): 342-5, 1994.
16. Menzies SW and McCarthy WH: Complete regression of primary cutaneous malignant melanoma. Arch Surg 132(5): 553-6, 1997.
17. Shields CL, Shields JA, Santos MC, Gunduz K, Singh AD and Othmane I: Uncomplete spontaneous regression of choroidal melanoma associated with inflammation. Arch Ophthalmol 117(9): 1245-7, 1999.
18. King M, Spooner D and Rowlands DC: Spontaneous regression of metastatic malignant melanoma of the parotid gland and neck lymph nodes: A case report and a review of the literature. Clin Oncol (R Coll Radiol) 13(6): 466-9, 2001
19. Kavoussi LR, Levine SR, Kadmon D and Fair WR: Regressioin of metastatic renal cell carcinoma: A case report and literature review. J Urol 135(5): 1005-7, 1986.
20. Lokich J: Spontaneous regression of metastatic renal cancer. Case report and literature review. Am J Clin Oncol 20(4): 416-8, 1997.
21. Hamid Y and Poller DN: Spontaneous regression of renal cell carcinoma: A pitfall in diagnosis of renal lesions. J Clin Pathol 51(4): 334-6, 1998.
22. Bowles AP Jr and Perkins E: Long-term remission of malignant brain tumors after intracranial infection: A report of four cases. Neurosurgery 44(3): 636-43, 1999.
23. Ifrah N, James JM, Viguie F, Marie JP and Zittoun R: Spontaneous remission in adult acute leukemia. Cancer 56(5): 1187-90, 1985.
24. Jehn UW and Mempel MA: Spontaneous remission of acute myeloid leukemia. A report of a case and brief review of the literature. Blut 52(3): 165-8, 1986.
25. Mitterbauer M, Fritzer-Szekeres M, Mitterbauer G, Simonitsch L, Knobl P, Rintelen C, Schwarzinger L., Haas OA, Silberbauer K, Frey K, Bibus B, Pabinger I, Radaszkiewicz T, Lechner K and Jaeger U: Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia. Ann Hematol 73(4): 189-93, 1996.
26. Zaheer W, Friedland NIL, Cooper EB, DoRosario A, Burd RM, Gagliardi J and Torstenson G: Spontaneous regression of small cell carcinoma of lung associated with severe neuropathy. Cancer Invest 11(3): 306-9, 1993.
27. Darnell RB, DeAngelis LM: Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 341(8836): 21-2, 1993.
28. Kappauf H, Gallmeier WM, Wunsch PH, Mittelmeier HO, Birkmann J, Buschel G, Kaiser G and Kraus J: Complete spontaneous remission in a patient with metastatic non-small-cell lung cancer. Case report, review of the literature, and discussion of possible biological pathways involved. Ann Oncol 8(10): 1031-9, 1997.
29. Carlsen NL: How frequent is spontaneous remission of neuroblastomas? Implications for screening. Br J Cancer 61(3): 441-6, 1990.
30. Matsumura M, Tsunoda A, Nishi T, Nishihira H and Sasaki Y: Spontaneous regression of neuroblastoma detected by mass screening. Lancet 17 338(8764): 447-8, 1991.
31. Bolande RP: The spontaneous regression of neuroblastoma. Experimental evidence for a natural host immunity. Pathol Annu 26 Pt 2: 187-99, 1991.
32. Lommatzsch PK, Zimmermann W and Lommatzsch R: Spontaneous growth inhibition in retinoblastoma. [Article in German] Klin Monatsbl Augenheilkd 202(3): 218-23, 1993.
33. Roberts BN, Pilz DT and Walters RF: Bilateral spontaneously regressed retinoblastoma with preservation of vision. Eye 11 (Pt 1): 122-4, 1997.
34. Kaczynski J, Hansson G, Remotti H and Wallerstedt S: Spontaneous regression of hepatocellular carcinoma. Histopathology 32(2): 147-50, 1998.
35. Stoelben E, Koch M, Hanke S, Lossnitzer A, Gaertner HJ, Schentke KU, Bunk A and Saeger HD: Spontaneous regression of hepatocellular carcinoma confirmed by surgical specimen: Report of two cases and review of the literature. Langenbecks Arch Surg 383(6): 447-52, 1998.
36. Takeda Y, Togashi H, Shinzawa H, Miyano S, Ishii R, Karasawa T, Takeda Y, Saito T, Saito K, Haga H, Matsuo T, Aoki M, Mitsuhashi H, Watanabe H and Takahashi T: Spontaneous regression of hepatocellular carcinoma and review of literature. J Gastroenterol Hepatol 15(9): 1079-86, 2000.
37. Ikeda M, Okada S, Ueno H, Okusaka T and Kuriyama H: Spontaneous regression of hepatocellular carcinoma with multiple lung metastases: A case report. Jpn J Clin Oncol 31(9): 454-8, 2001.
38. Ohwada S, Miyamoto Y, Fujii T, Oyama T, Joshita T and Izuo M: Spontaneous regression of esophageal carcinoma with pulmonary metastases: Case report. Jpn J Clin Oncol 20(2): 193-8, 1990.
39. Vergeau B, Molinie C, Grandpieffe G and Vindrios J: Spontaneous partial elimination of a carcinoma of the esophagus. Gastrointest Endosc 37(5): 591, 1991.
40. Ogihara Y, Takeda K, Yanagawa T and Hirasawa Y: Spontaneous regression of lung metastases from osteosarcoma. Cancer 74(10): 2798-803, 1994.
41. Lei KI, Gwi E, Ma L, Liang EY and Johnson PJ: 'Spontaneous' regression of advanced leiomyosarcoma of the urinary bladder. Oncology 54(1): 19-22, 1997.
42. Daniels D, Lowdell CP and Glaser MG: The spontaneous regression of lymphoma in AIDS. Clin Oncol (R Coll Radiol) 4(3): 196-7, 1992.
43. Terriff BA, Harrison P and Holden JK: Apparent spontaneous regression of AIDS related primary CNS lymphoma mimicking resolving toxoplasmosis. J Acquir Immune Defic Syndr 5(9): 953-4, 1992.
44. Soffells T, Pratt L, Newton J, Graham S and Ryan M: Spontaneous regression of granulomatous mycosis fungoides in an HIV positive patient. J Am Acad Dermatol 37(5 Pt 2): 876-80, 1997.
45. Kaiser HE: Biological viewpoints of neoplastic regression. In Vivo. 8(1): 155-65, 1994.
46. Kaiser HE: Cancer Growth and Progression. Kluwer Academic Press, 1989.
47. Bodey B, Bodey B Jr and Kaiser HE: Involution of the mammalian thymus during its normal histogenesis and under various in vitro and in vivo experimental conditions. In Vivo 12(1): 123-134, 1998.
48. Kaiser HE, Krenn M, Bodey B Jr and Bodey B: Involution and neoplasms of the thymus. In Vivo 14(1): 189-198, 2000.
49. Marincola FM, Jaffee EM, Hicklin DJ and Ferrone S: Escape of human solid tumors from T-cell recognition: Molecular mechanisms and functional significance. Adv Immunol 74: 181-273, 2000.
50. Cole WH: Efforts to explain spontaneous regression of cancer. J Surg Oncol 17(3): 201-9, 1981.
51. Wyczolkowski M, Klima W, Bieda W and Walas K: Spontaneous regression of hepatic metastases after nephrectomy and metastasectomy of renal cell carcinoma. Urol Int 66(2): 119-20, 2001.
52. Yoo YK, Heo DS, Hata K, Van Thiel DH and Whiteside TL: Tumor infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2. Gastroenterology 98(2): 259-268, 1990.
53. Robbins P and Kawakami Y: Human tumor antigens recognized by T cells. Curr Opin Immunol 8: 628-636, 1996.
54. Schiltz PM, Beutel LD, Nayak SK and Dillman RO: Characterization of tumor infiltrating lymphocytes derived from human tumors for use as adoptive immunotherapy of cancer. J Immunother 20(5): 377-386, 1997.
55. Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM and Schlom J: Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J Natl Cancer Inst 87: 982-990, 1995.
56. Calhoun RF 2nd, Naziruddin B, Enriquez-Rincon F, Duffy BF, Ritter JM, Sundaresan S, Patterson GA, Cooper JD and Mohanakumar T: Evidence for cytotoxic T lymphocyte response against human lung cancer: Reconstitution of antigenic epitope with peptide eluted from lung adenocarcinoma MHC class 1. Surgery 128(1): 76-85, 2000.
57. Nicholls PK, Moore PF, Anderson DM, Moore RA, Parry NR, Gough GW and Stanley MA: Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes. Virology 283(1): 31-9, 2001.
58. Patel A, Halliday GM, Cooke BE and Bametson RS: Evidence that regression in keratoacanthoma is immunologically mediated: A comparison with squamous cell carcinoma. Br J Dermatol 131(6): 789-98, 1994.
59. Kerr KM, Johnson SK, King G, Kennedy MM, Weir J and Jeffrey R: Partial regression in primary carcinoma of the lung: Does it occur? Histopathology 33(1): 55-63, 1998.
60. Ono K, Kikuchi M, Funai N, Matsuzaki M and Shimarnoto Y: Natural killing activity in patients with spontaneous regression of malignant lymphoma. J Clin Immunol 16(6): 334-9, 1996.
61. Nagorsen D, Keilholz U, Rivoltini L, Schmittel A, Letsch A, Asemissen AM, Berger G, Buhr HJ, Thiel E and Scheibenbogen C: Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. Cancer Res 1 60(17): 4850-4, 2000.
62. Feuerer M, Beckhove P, Bai L, Solomayer EF, Bastert G, Diel IJ, Pedain C, Oberniedermayr M, Schirrmacher V and Umansky V: Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow. Nat Med 7(4): 452-8, 2001.
63. Wiernik PH: Spontaneous regression of hematologic cancers. Natl Cancer Inst Monogr Nov 44: 35-8, 1976.
64. Kleef R, Jonas WB, Knogler W and Stenzinger W: Fever, cancer incidence and spontaneous remissions. Neuroimmunomodulation 9(2): 55-64, 2001.
65. Hoption Cann SA, Van Netten JP, Van Netten C and Glover DW: Spontaneous regression: A hidden tressure buried in time. Med Hypotheses 58(2): 115-9, 2002.
66. O'Reagan B and Hirschberg C: Spontaneous Remission. An Annotated Bibliography. Sausalito. Institute of Noetic Sciences. 1993.
67. Lachant NA, Goldberg J, Nelson DA and Gottlieb AJ: Spontaneous remission in acute myelogenous leukemia in the adult. Am J Med 67(4): 687-92, 1979.
68. Garcia-Rayo S, Gurpide A, Vega F and Brugarolas A: Spontaneous tumor regression in a patient with multiple myeloma. Report of another case. Rev Med Univ Navarra 40(3): 41-2 [Article in Spanish], 1996.
69. Busch W: Aus der Sitzung der medicinischen Section vom 13 November 1867. Berl Klin Wochenschr 5: 137, 1868.
70. Coley WB: A preliminary note on the treatment of inoperable sarcoma by the toxic product of erysipelas. Post-graduate 8: 278, 1893.
71. Starnes CO: Coley's toxins in perspective. Nature 357: 12, 1992.
72. Coley-Nauts H and McLauren, JR: Coley toxin - The first century. Adv Exp Med Biol 267: 483, 1990.
73. Hobohm U: Fever and cancer in perspective. Cancer Immunol Immunother 50(8): 391-6, 2001.
74. Morales A, Eidinger D and Bruce AW: Intracavity bacillus Calmette-Guerin in the treatment of superficial bladder tumours. J Urol 137: 180-3, 1976.
75. McCune CS, Patterson WB and Henshaw EC: Active specific immunotherapy with tumor cells and Corynebacterium parvum: A phase I study. Cancer 43(5): 1619-23, 1979.
76. Lamm DL, Reichert DF, Radwin HM and Thor DE: Bacillus Calmette-Guerin immunotherapy of the cancer-contaminated wound. J Surg Res 27(1): 14-22, 1979.
77. W.H.O. Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Melanoma. Controlled study with imidazole carboxamide (DTIC), DTIC + bacillus Calmette-Guerin (BCG), and DTIC + Corynebacterium parvum in advanced malignant melanoma. Tumori 70(1): 41-8, 1984.
78. Guinan P, Crispen R and Rubenstein M: BCG in management of superficial bladder cancer. Urology 30(6): 515-9, 1987.
79. Van Der Meijden AP: Non-specific immunotherapy with bacille Calmette-Guerin (BCG). Clin Exp Immunol 123(2): 179-80, 2001.
80. Kim JC and Steinberg GD: The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder. J Urol 165(3): 745-56, 2001.
81. Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, Freezer I-J, Morton KE, Seipp C, Haworth L, Mavroukakis S, White D, MacDonald KE, Mao J, Sznol M and Rosenberg SA: Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 20(1): 142-52, 2002.
82. Vermorken JB, Claessen AM, Van Tinteren H, Gall HE, Ezinga R, Meijer S, Scheper RJ, Meijer CJ, Bloemena E, Ransom JH, Hanna MG Jr and Pinedo HM: Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial. Lancet 353(9150): 345-50, 1999.
83. Unger C, Haring B, Kruse A, Thumann A, Schneider B, Clemm C, Weber B, Clevert HD, Hockertz S and Kalousek MB: Double-blind randomised placebo controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer. Arzneimittelforschung 51(4): 332-8, 2001.
84. Chung TH, Jun JB, Jang JW and Chung HL: Regression of an acral lentiginous melanoma with an immunotherapy using a Mycobacterium tuberculosis-extracted polysaccharide complex (Tubercin). Int J Dermatol 41(1): 52-3, 2002.
85. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA and Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374(6522): 546-9, 1995.
86. Hartmann G, Weiner GJ and Krieg AM: CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci U S A 96(16): 9305-10, 1999.
87. Bauer M, Redecke V, Ellwart JW, Scherer B,Kremer JP, Wagner H and Lipford GB: Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J Immunol 166(8): 5000-7, 2001.
88. Miconnet L., Koenig S, Speiser D, Krieg A, Guillaume P, Cerottini JC and Romero P: CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide. J Immunol 168(3): 1212-8, 2002.
89. Glauser MP, Zanetti G, Baumgartner JD and Cohen J: Spetic shock: Pathogenesis. Lancet 338: 732-736, 1991.
90. Hoffmann JA, Kafatos FC, Janeway CA, Jr and Ezekowitz RAB: Phylogenetic perspectives in innate immunity. Science (Wash DC) 284: 1313-1318, 1999.
91. Chow JC, Young DW, Golenbock DT, Christ WJ and Gusovsky F: Toll-like receptor-4 mediates lipopolysacchande-induced signal transduction. J Biol Chem 274: 10689-10692, 1999.
92. De Smedt T, PaJak B, Muraille E, Lespagnard L, Heinen E, De Baetselier P, Urbain J, Leo O and Moser M: Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 184(4): 1413-24, 1996.
93. Lanzavecchia A: Dendritic cell maturationa and generation of immune responses. Haematologica 84 Suppl EHA-4: 23-5, 1999.
94. Lapointe R, Toso JF, Butts C, Young HA and Hwu P: Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen -specific T lymphocytes. Eur J Immunol 30(11): 3292-8, 2000.
95. Steinman RM and Dhodapkar M: Active immunization against cancer with dendritic cells: The near future. Int J Cancer 94(4): 459-73, 2001.
96. Jonuleit H, Giesecke-Tuettenberg A, Tuting T, Thurner-Schuler B Stuge TB, Paragnik L, Kandemir A, Lee PP, Schuler G, Knop J and Enk AH; A comparison of two types of dendritic cells as adjuvants for the induction of melanoma-specific T cells responses in humans following intranodal injection. Int J Cancer 93: 243-51, 2001.
97. Miconnet I, Coste I, Beermann F, Hauew JF, Cerottini JC, Bonnefoy JY, Romero P and Renno T: Cancer vaccine design: A novel bacterial adjuvant for peptide-specific CTL induction. J Immunol 166(7): 4612-9, 2001.
98. McClain K, Warkentin P and Kay N: Spontaneous remission of Burkitt's lymphoma associated with herpes zoster infection. Am J Pediatr Hematol Oncol Spring 7(1): 914, 1985.
99. Frick S and Frick P: Spontanremission in Chronischer Lymphatischer Leukdmie Schweiz Med Wochenschr 123(8): 328-34, 1993.
100. Tzankov A, Ludescher C, Duba HC, Steinlechner M, Knapp R, Schmid T, Grunewald K, Gastl G and Stauderr R: Spontaneous remission in a secondary acute myelogenous leukaemia following invasive pulmonary aspergillosis. Ann Hematol 80(7): 423-5, 2001.
101. Fassas A, Sakellari L., Anagnostopoulos A and Saloum R: Spontaneous remission of acute myeloid leukemia in a patient with concurrent Pneumocystis carinii pneumonia. Nouv Rev Fr Hematol 3395: 363-4, 1991.
102. Medzhitov R and Janeway CA Jr: Decoding the patterns of self and nonself by the innate immune system. Science 296(5566): 298-300, 2002.
103. Matzinger P: The danger model: A renewed sense of self. Science 296(5566): 301-5, 2002.
104. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI and Blaser MJ: Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 83(23): 1734-9, 1991.
105. EUROGAST Study Group: An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993 May 29; 341(8857): 1359-62 Erratum in: Lancet 341(8861): 1668, 1993.
106. Hunt RH, Sumanac K and Huang JO: Review article: Should we kill or should we save Helicobacter pylori? Aliment Pharmacol Ther 15 Suppl 1: 51-9, 2001.